[Federal Register Volume 85, Number 224 (Thursday, November 19, 2020)]
[Notices]
[Page 73674]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25542]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-47-2020]


Foreign-Trade Zone (FTZ) 49--Newark and Elizabeth, New Jersey; 
Authorization of Production Activity; Catalent Pharma Solutions 
(Pharmaceutical Products), Somerset, New Jersey

    On July 17, 2020, Catalent Pharma Solutions submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 49T, in Somerset, New Jersey.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (85 FR 47166-47167, August 4, 2020). 
On November 16, 2020, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: November 16, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020-25542 Filed 11-18-20; 8:45 am]
BILLING CODE 3510-DS-P